Edition:
United Kingdom

People: Cumberland Pharmaceuticals Inc (CPIX.OQ)

CPIX.OQ on NASDAQ Stock Exchange Global Select Market

5.45USD
19 Jul 2019
Change (% chg)

$-0.25 (-4.39%)
Prev Close
$5.70
Open
$5.64
Day's High
$5.67
Day's Low
$5.40
Volume
24,770
Avg. Vol
5,297
52-wk High
$7.00
52-wk Low
$5.11

Rock, Amy 

Dr. Amy Dix Rock, Ph.D., is Vice President - Regulatory & Scientific Affairs of Cumberland Pharmaceuticals Inc. She was Senior Director, Regulatory and Scientific Affairs. Dr. Rock joined the company in 2001 and built Regulatory Affairs Department and infrastructure. In addition to managing all interactions between the company and the FDA, Dr. Rock oversees the preparation of pre-approval and post-approval regulatory submissions. Her additional responsibilities include involvement in protocol development and clinical trials management, overseeing the medical call center and supporting the corporate compliance initiatives. She holds a B.A. from Washington University, a Ph.D. in Immunology from the University of Kentucky, and an M.B.A. from the Vanderbilt Owen Graduate School of Management.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

A. Kazimi

995,950

Michael Bonner

--

Martin Cearnal

383,240

Leo Pavliv

472,100

James Herman

299,745

Amy Rock

--
As Of  31 Dec 2014